Your browser doesn't support javascript.
loading
A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro.
Guo, Qi; Xu, Liyun; Tan, Fusheng; Zhang, Yongjie; Fan, Junsheng; Wang, Xinghai; Zhang, Zhemin; Li, Bing; Chu, Haiqing.
Afiliação
  • Guo Q; Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Xu L; Tongji University School of Medicine, Shanghai, China.
  • Tan F; Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Zhang Y; MicuRx Pharmaceuticals, Inc., Shanghai, China.
  • Fan J; Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Wang X; Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Zhang Z; Tongji University School of Medicine, Shanghai, China.
  • Li B; MicuRx Pharmaceuticals, Inc., Shanghai, China.
  • Chu H; Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Antimicrob Agents Chemother ; 65(11): e0088921, 2021 10 18.
Article em En | MEDLINE | ID: mdl-34460305

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxazolidinonas / Mycobacterium abscessus / Infecções por Mycobacterium não Tuberculosas Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxazolidinonas / Mycobacterium abscessus / Infecções por Mycobacterium não Tuberculosas Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article